BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hiraoka A, Kawamura T, Aibiki T, Okudaira T, Toshimori A, Yamago H, Nakahara H, Suga Y, Azemoto N, Miyata H, Miyamoto Y, Ninomiya T, Murakami T, Ishimaru Y, Kawasaki H, Hirooka M, Abe M, Matsuura B, Hiasa Y, Michitaka K. Prognosis and therapy for ruptured hepatocellular carcinoma: problems with staging and treatment strategy. Eur J Radiol 2015;84:366-71. [PMID: 25554005 DOI: 10.1016/j.ejrad.2014.11.038] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mahmoud YI, Shehata AMM, Fares NH, Mahmoud AA. Spirulina inhibits hepatocellular carcinoma through activating p53 and apoptosis and suppressing oxidative stress and angiogenesis. Life Sci 2021;265:118827. [PMID: 33253720 DOI: 10.1016/j.lfs.2020.118827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Pan QX, Su ZJ, Zhang JH, Wang CR, Ke SY. Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinoma. Mol Clin Oncol 2017;6:566-74. [PMID: 28413670 DOI: 10.3892/mco.2017.1166] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
3 Wang YM, Lyon J, Yoon JM. Transcatheter arterial embolization as palliation in metastatic hepatocellular carcinoma. Pediatr Blood Cancer 2019;66:e27754. [PMID: 30977585 DOI: 10.1002/pbc.27754] [Reference Citation Analysis]
4 Sakisaka M, Haruta M, Komohara Y, Umemoto S, Matsumura K, Ikeda T, Takeya M, Inomata Y, Nishimura Y, Senju S. Therapy of primary and metastatic liver cancer by human iPS cell-derived myeloid cells producing interferon-β. J Hepatobiliary Pancreat Sci 2017;24:109-19. [PMID: 28008721 DOI: 10.1002/jhbp.422] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
5 Xia F, Zhu P, Chen XP, Zhang BX, Zhang MY. Prognostic Analysis of Postoperative Survival for Ruptured Hepatocellular Carcinoma with or without Cirrhosis. J Oncol 2022;2022:7531452. [PMID: 35342424 DOI: 10.1155/2022/7531452] [Reference Citation Analysis]
6 Jeng KS, Huang CC, Lin CC, Lin CK, Teng CJ, Chen KH. Liver Transplantation After Downstagings of Ruptured Advanced Hepatocellular Carcinoma in Cirrhotic Liver: Is It Advisable? A Case Report. Transplant Proc 2019;51:1468-71. [PMID: 31056250 DOI: 10.1016/j.transproceed.2019.01.125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
7 Qin H, Yang S, Cai S, Ren Q, Han W, Yang W, Cheng H, Ma X, Wang H. Clinical characteristics and risk factors of 47 cases with ruptured neuroblastoma in children. BMC Cancer 2020;20:243. [PMID: 32293329 DOI: 10.1186/s12885-020-06720-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Lan X, Xiang Y, Liu F, Li B, Wei Y, Zhang H. Massive hemoperitoneum and upper gastrointestinal hemorrhage following liver rupture secondary to gallbladder perforation: A case report and literature review. Medicine (Baltimore) 2019;98:e14729. [PMID: 30882639 DOI: 10.1097/MD.0000000000014729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Kwon JH, Song GW, Hwang S, Kim KH, Ahn CS, Moon DB, Ha TY, Jung DH, Park GC, Yoon YI, Shim JH, Kim KW, Lee SG. Surgical Outcomes of Spontaneously Ruptured Hepatocellular Carcinoma. J Gastrointest Surg 2021;25:941-53. [PMID: 32246392 DOI: 10.1007/s11605-020-04555-0] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chan WH, Hung CF, Pan KT, Lui KW, Huang YT, Lin SY, Lin YY, Wu TH, Yu MC. Impact of spontaneous tumor rupture on prognosis of patients with T4 hepatocellular carcinoma. J Surg Oncol 2016;113:789-95. [PMID: 27062288 DOI: 10.1002/jso.24245] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
11 Zhang W, Zhang ZW, Zhang BX, Huang ZY, Zhang WG, Liang HF, Chen XP. Outcomes and Prognostic Factors of Spontaneously Ruptured Hepatocellular Carcinoma. J Gastrointest Surg 2019;23:1788-800. [PMID: 30328072 DOI: 10.1007/s11605-018-3930-7] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
12 Xia F, Huang Z, Zhang Q, Ndhlovu E, Zhang M, Chen X, Chen Y, Zhang B, Zhu P. Hepatectomy for ruptured hepatocellular carcinoma classified as Barcelona Clinic Liver Cancer stage 0/A: The optimal treatment. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.05.006] [Reference Citation Analysis]
13 Sun J, Li Y, Wang Y, Liu Y, Liu Y, Wang X. Comparison of anti-HBV regimen with or without adefovir on hepatocellular carcinoma development of Chronic hepatitis B patients with compensated cirrhosis: a retrospective cohort study. Infect Agent Cancer 2018;13:17. [PMID: 29796061 DOI: 10.1186/s13027-018-0189-2] [Reference Citation Analysis]
14 Zhang P, Liu Q, Yuan M, Wang L. Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis. Infect Agent Cancer 2018;13:30. [PMID: 30181772 DOI: 10.1186/s13027-018-0203-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Cui SX, Shi WN, Song ZY, Wang SQ, Yu XF, Gao ZH, Qu XJ. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways. Oncotarget 2016;7:36767-82. [PMID: 27167344 DOI: 10.18632/oncotarget.9168] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
16 Yang Y, Liu Q, Li Z, Zhang R, Jia C, Yang Z, Zhao H, Ya S, Mao R, Ailijiang T, Bao Y, Zhang H. GP73 promotes epithelial–mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma. Carcinogenesis 2018;39:900-10. [DOI: 10.1093/carcin/bgy010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
17 Ren F, Li J, Yuan X, Wang Y, Wu K, Kang L, Luo Y, Zhang H, Yuan Z. Dandelion polysaccharides exert anticancer effect on Hepatocellular carcinoma by inhibiting PI3K/AKT/mTOR pathway and enhancing immune response. Journal of Functional Foods 2019;55:263-74. [DOI: 10.1016/j.jff.2019.02.034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Moris D, Chakedis J, Sun SH, Spolverato G, Tsilimigras DI, Ntanasis-stathopoulos I, Spartalis E, Pawlik TM. Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: A systematic review. J Surg Oncol 2018;117:341-53. [DOI: 10.1002/jso.24869] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]